Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

Pathogenesis of Burkholderia pseudomallei and Burkholderia mallei.

Larsen JC, Johnson NH.

Mil Med. 2009 Jun;174(6):647-51. Review.

PMID:
19585782
[PubMed - indexed for MEDLINE]
2.

Burkholderia mallei and Burkholderia pseudomallei: the causative micro-organisms of glanders and melioidosis.

Gilad J.

Recent Pat Antiinfect Drug Discov. 2007 Nov;2(3):233-41. Review.

PMID:
18221181
[PubMed - indexed for MEDLINE]
3.

Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.

Galyov EE, Brett PJ, DeShazer D.

Annu Rev Microbiol. 2010;64:495-517. doi: 10.1146/annurev.micro.112408.134030. Review.

PMID:
20528691
[PubMed - indexed for MEDLINE]
4.

[Molecular-genetic approaches to diagnosis and intraspecific typing of causative agents of glanders and melioidosis].

Antonov VA, Iliukhin VI.

Mol Gen Mikrobiol Virusol. 2005;(2):3-9. Review. Russian.

PMID:
15954468
[PubMed - indexed for MEDLINE]
5.

Burkholderia mallei and Burkholderia pseudomallei as bioterrorism agents: national aspects of emergency preparedness.

Gilad J, Harary I, Dushnitsky T, Schwartz D, Amsalem Y.

Isr Med Assoc J. 2007 Jul;9(7):499-503. Review. No abstract available.

PMID:
17710778
[PubMed - indexed for MEDLINE]
Free Article
6.

Melioidosis research in China.

Yang S.

Acta Trop. 2000 Nov 2;77(2):157-65. Review. Erratum in: Acta Trop. 2008 Jun;106(3):221.

PMID:
11080506
[PubMed - indexed for MEDLINE]
7.

The use of animal infection models to study the pathogenesis of melioidosis and glanders.

Woods DE.

Trends Microbiol. 2002 Nov;10(11):483-4; discussion 484-5. Review.

PMID:
12419603
[PubMed - indexed for MEDLINE]
8.

Development of Burkholderia mallei and pseudomallei vaccines.

Silva EB, Dow SW.

Front Cell Infect Microbiol. 2013 Mar 11;3:10. doi: 10.3389/fcimb.2013.00010. eCollection 2013. Review.

PMID:
23508691
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Glanders.

Dvorak GD, Spickler AR.

J Am Vet Med Assoc. 2008 Aug 15;233(4):570-7. doi: 10.2460/javma.233.4.570. Review. No abstract available.

PMID:
18710311
[PubMed - indexed for MEDLINE]
10.

Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.

Bondi SK, Goldberg JB.

Expert Rev Vaccines. 2008 Nov;7(9):1357-65. doi: 10.1586/14760584.7.9.1357. Review.

PMID:
18980539
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Glanders: off to the races with Burkholderia mallei.

Whitlock GC, Estes DM, Torres AG.

FEMS Microbiol Lett. 2007 Dec;277(2):115-22. Review.

PMID:
18031330
[PubMed - indexed for MEDLINE]
12.

Recent development in melioidosis.

Leelarasamee A.

Curr Opin Infect Dis. 2004 Apr;17(2):131-6. Review.

PMID:
15021053
[PubMed - indexed for MEDLINE]
13.

[Glanders--a comprehensive review].

Wittig MB, Wohlsein P, Hagen RM, Al Dahouk S, Tomaso H, Scholz HC, Nikolaou K, Wernery R, Wernery U, Kinne J, Elschner M, Neubauer H.

Dtsch Tierarztl Wochenschr. 2006 Sep;113(9):323-30. Review. German.

PMID:
17009807
[PubMed - indexed for MEDLINE]
14.

Advances and remaining uncertainties in the epidemiology of Burkholderia pseudomallei and melioidosis.

Currie BJ.

Trans R Soc Trop Med Hyg. 2008 Mar;102(3):225-7. doi: 10.1016/j.trstmh.2007.11.005. Epub 2007 Dec 31. Review.

PMID:
18166205
[PubMed - indexed for MEDLINE]
15.

Current studies on the pathogenesis of melioidosis.

Woods DE, DeShazer D, Moore RA, Brett PJ, Burtnick MN, Reckseidler SL, Senkiw MD.

Microbes Infect. 1999 Feb;1(2):157-62. Review.

PMID:
10594980
[PubMed - indexed for MEDLINE]
16.

The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease?

Lazar Adler NR, Govan B, Cullinane M, Harper M, Adler B, Boyce JD.

FEMS Microbiol Rev. 2009 Nov;33(6):1079-99. doi: 10.1111/j.1574-6976.2009.00189.x. Epub 2009 Aug 5. Review.

PMID:
19732156
[PubMed - indexed for MEDLINE]
17.

Exopolysaccharides of Burkholderia pseudomallei.

Steinmetz I, Nimtz M, Wray V, Häussler S, Reganzerowski A, Brenneke B.

Acta Trop. 2000 Feb 5;74(2-3):211-4. Review. No abstract available.

PMID:
10674651
[PubMed - indexed for MEDLINE]
18.

Genetics and function of the capsules of Burkholderia pseudomallei and their potential as therapeutic targets.

Reckseidler-Zenteno SL, Moore R, Woods DE.

Mini Rev Med Chem. 2009 Feb;9(2):265-71. Review.

PMID:
19200030
[PubMed - indexed for MEDLINE]
19.

Immunity to Burkholderia pseudomallei.

Wiersinga WJ, van der Poll T.

Curr Opin Infect Dis. 2009 Apr;22(2):102-8. doi: 10.1097/QCO.0b013e328322e727. Review.

PMID:
19276877
[PubMed - indexed for MEDLINE]
20.

An objective approach for Burkholderia pseudomallei strain selection as challenge material for medical countermeasures efficacy testing.

Van Zandt KE, Tuanyok A, Keim PS, Warren RL, Gelhaus HC.

Front Cell Infect Microbiol. 2012 Sep 26;2:120. doi: 10.3389/fcimb.2012.00120. eCollection 2012. Review.

PMID:
23057010
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk